Literature DB >> 9032640

Fragile X syndrome is less common than previously estimated.

J E Morton1, S Bundey, T P Webb, F MacDonald, P M Rindl, S Bullock.   

Abstract

In 1986, a population study of school children in the city of Coventry gave an overall prevalence in males and females for fragile X syndrome of 1/952. The 29 children diagnosed as having fragile X syndrome in this study have been re-evaluated with molecular diagnostic techniques. Eighteen of the original 29 children have been found not to have the expansion of the FMR1 gene associated with fragile X syndrome. Revised prevalence figures have been calculated giving rise to an overall prevalence figure of 1/2720 (range 1/2198-1/3089). If the four children lost to follow up are also assumed not to have the fragile X syndrome, the revised prevalence figure was 1/5714 (range 1/4762-1/6349). Clinical review of boys with severe mental retardation from this and a subsidiary study show that the clinical features of head circumference greater than the 50th centile, testicular volume greater than the 50th centile, and IQ between 35 and 70 remain helpful in distinguishing boys with fragile X syndrome from those who have non-specific mental retardation.

Entities:  

Mesh:

Year:  1997        PMID: 9032640      PMCID: PMC1050837          DOI: 10.1136/jmg.34.1.1

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  27 in total

1.  FRAXE expansion is not a common etiological factor among developmentally delayed males.

Authors:  D J Allingham-Hawkins; P N Ray
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

2.  Clinical screening score for the fragile X (Martin-Bell) syndrome.

Authors:  S Laing; M Partington; H Robinson; G Turner
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

3.  Fragile X checklist.

Authors:  R J Hagerman; K Amiri; A Cronister
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

4.  Prevalence of the fragile X syndrome in four birth cohorts of children of school age.

Authors:  M Kähkönen; T Alitalo; E Airaksinen; R Matilainen; K Launiala; S Autio; J Leisti
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

5.  The frequency of the fragile X chromosome among schoolchildren in Coventry.

Authors:  T P Webb; S Bundey; A Thake; J Todd
Journal:  J Med Genet       Date:  1986-10       Impact factor: 6.318

6.  Preventive screening for the fragile X syndrome.

Authors:  G Turner; H Robinson; S Laing; S Purvis-Smith
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245

7.  Fragile X syndrome: recognition in young children.

Authors:  A Simko; L Hornstein; S Soukup; N Bagamery
Journal:  Pediatrics       Date:  1989-04       Impact factor: 7.124

8.  The common fragile site in band q27 of the human X chromosome is not coincident with the fragile X.

Authors:  G R Sutherland; E Baker
Journal:  Clin Genet       Date:  1990-03       Impact factor: 4.438

9.  Prevalence of the fragile-X syndrome in mentally retarded boys in a Swedish county.

Authors:  K H Gustavson; H K Blomquist; G Holmgren
Journal:  Am J Med Genet       Date:  1986 Jan-Feb

10.  FRAXE and mental retardation.

Authors:  J C Mulley; S Yu; D Z Loesch; D A Hay; A Donnelly; A K Gedeon; P Carbonell; I López; G Glover; I Gabarrón
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

View more
  18 in total

1.  Living with genetic risk: effect on adolescent self-concept.

Authors:  Allyn McConkie-Rosell; Gail A Spiridigliozzi; Elizabeth Melvin; Deborah V Dawson; Ave M Lachiewicz
Journal:  Am J Med Genet C Semin Med Genet       Date:  2008-02-15       Impact factor: 3.908

2.  High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique.

Authors:  Jennifer Yuhas; Paulina Walichiewicz; Ruiqin Pan; Wenting Zhang; E Melina Casillas; Randi J Hagerman; Flora Tassone
Journal:  Genet Test Mol Biomarkers       Date:  2009-12

3.  FRAXA and FRAXE: the results of a five year survey.

Authors:  S A Youings; A Murray; N Dennis; S Ennis; C Lewis; N McKechnie; M Pound; A Sharrock; P Jacobs
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

4.  Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.

Authors:  Allyn McConkie-Rosell; Brenda Finucane; Amy Cronister; Liane Abrams; Robin L Bennett; Barbara J Pettersen
Journal:  J Genet Couns       Date:  2005-08       Impact factor: 2.537

5.  Genetic Counseling for Fragile X Syndrome: Recommendations of the National Society of Genetic Counselors.

Authors:  N McIntosh; L W Gane; A McConkie-Rosell; R L Bennett
Journal:  J Genet Couns       Date:  2000-08       Impact factor: 2.537

Review 6.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

7.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Genetic risk communication: experiences of adolescent girls and young women from families with fragile X syndrome.

Authors:  Allyn McConkie-Rosell; Elizabeth Melvin Heise; Gail A Spiridigliozzi
Journal:  J Genet Couns       Date:  2009-03-11       Impact factor: 2.537

9.  Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.

Authors:  Allyn McConkie-Rosell; Liane Abrams; Brenda Finucane; Amy Cronister; Louise W Gane; Sarah M Coffey; Stephanie Sherman; Lawrence M Nelson; Elizabeth Berry-Kravis; David Hessl; Sufen Chiu; Natalie Street; Ajay Vatave; Randi J Hagerman
Journal:  J Genet Couns       Date:  2007-05-12       Impact factor: 2.537

10.  Cystic fibrosis carrier frequencies in populations of African origin.

Authors:  C Padoa; A Goldman; T Jenkins; M Ramsay
Journal:  J Med Genet       Date:  1999-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.